References
- Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA 2013; 310:1353–68
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103–11
- Chen FP, Chien MH, Chen HY, Ng YT. Effects of different progestogens on human breast tumor cell growth. Climacteric 2011;14:345–51
- Gomes AM, Stelling MP, Pavão MS. Heparan sulfate and heparanase as modulators of breast cancer progression. Biomed Res Int 2013;2013:852093
- Raman K, Kuberan B. Chemical tumor biology of heparan sulfate proteoglycans. Curr Chem Biol 2010;4:20–31
- Nerlich AG, Lebeau A, Hagedorn HG, Sauer U, Schleicher ED. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Anti-cancer Res 1998;18(5A):3515–20
- Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry 2008;47: 11174–83
- Hadler-Olsen E, Winberg JO, Uhlin-Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour Biol 2013;34:2041–51
- Giannelli G, Pozzi A, Stetler-Stevenson WG, Gardner HA, Quaranta V. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am J Pathol 1999;154:1193–201
- Ambili M, Jayasree K, Sudhakaran PR. 60K gelatinase involved in mammary gland involution is regulated by beta-oestradiol. Biochim Biophys Acta 1998;1403:219–31
- Pompei LM, Steiner ML, Theodoro TR, et al. Effect of estrogen therapy on vascular perlecan and metalloproteinases 2 and 9 in castrated rats. Climacteric 2013;16:147–53
- Pompei LM, Carvalho FM, Ortiz SC, Motta MC, Cruz RJ, Melo NR. Morphometric evaluation of effects of two sex steroids on mammary gland of female rats. Maturitas 2005;51:370–9
- Cline JM, Register TC, Clarkson TB. Effects of tibolone and hormone replacement therapy on the breast of cynomolgus monkeys. Menopause 2002;9:422–9
- Conner P, Register TC, Skoog L, et al. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. Am J Obstet Gynecol 2005;193:58–63
- Cummings SR, Ettinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697–708
- Wren BG. The origin of breast cancer. Menopause 2007; 14:1060–8